{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-016414","form_type":"8-K","ticker":"PETS","cik":"0001040130","company_name":"PETMED EXPRESS INC","filed_at":"2021-07-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.940267+00:00","generated_at":"2026-06-30T07:06:36.529463+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"PetMed Express appoints CFO Bruce Rosenbloom as interim CEO following Menderes Akdag's departure","bullets":["CEO Menderes Akdag's employment contract ends July 30, 2021; Board decided not to extend.","CFO Bruce Rosenbloom appointed Interim CEO and President effective July 31, 2021; he remains CFO.","Rosenbloom receives additional $10,000/month cash stipend for interim CEO duties.","Board expects to appoint permanent CEO within ~3 months (by Oct 31, 2021).","No new severance arrangement; Rosenbloom's existing change-of-control severance unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-016414","json":"https://secwatch.observer/filing/0001437749-21-016414.json","markdown":"https://secwatch.observer/filing/0001437749-21-016414.md","text":"https://secwatch.observer/filing/0001437749-21-016414.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000143774921016414/0001437749-21-016414-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000143774921016414/pets20210705_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T07:06:36.529463+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"80f1daafd0","claim":"Bruce S. Rosenbloom was appointed as Interim Chief Executive Officer and President at PETMED EXPRESS INC.","evidence_excerpt":"the Board appointed Bruce S. Rosenbloom, the Company’s Chief Financial Officer, as Interim Chief Executive Officer (principal executive officer) and President of the Company, effective upon Mr. Akdag’s departure","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1040130/000143774921016414/0001437749-21-016414-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer and President"}],"fact_type":"executive_change"},{"claim_id":"aae02c04bd","claim":"Menderes Akdag departed as President and Chief Executive Officer at PETMED EXPRESS INC.","evidence_excerpt":"the Company will not extend Mr. Akdag’s employment agreement with the Company and that the employment agreement would therefore end on July 30, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1040130/000143774921016414/0001437749-21-016414-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not extended"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}